This inventor holds 1 USPTO granted patent. Top assignee: Oncotech, Inc.. Active years: 1988.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1988
Title: Innovations in Cancer Detection by Levy Kopelovich
Introduction
Levy Kopelovich is a notable inventor based in St. Petersburg, FL (US). He has made significant contributions to the field of cancer research through his innovative work. His expertise lies in developing methods that enhance the understanding of cancer susceptibility.
Latest Patents
Kopelovich holds a patent for a cancer susceptibility test. This invention relates to an improved viral transformation/neodifferentiation assay for determining predisposition to cancer. The invention is based on the association between retroviral transformation/neodifferentiation and a predisposition to cancer. The level of lipogenic enzymes is measured in cultured human fibroblast cells after transformation/neodifferentiation with Kirsten murine sarcoma virus in the presence of glucocorticosteroids. This method monitors the extent of conversion of human skin fibroblasts to fully mature adipocytes.
Career Highlights
Levy Kopelovich has dedicated his career to advancing cancer research. He works at Oncotech, Inc., where he applies his knowledge and skills to develop innovative solutions for cancer detection and treatment. His work has the potential to significantly impact the way cancer susceptibility is assessed.
Collaborations
(Section skipped due to space constraints.)
Conclusion
Levy Kopelovich's contributions to cancer research through his innovative patent demonstrate his commitment to improving cancer detection methods. His work at Oncotech, Inc. continues to pave the way for advancements in understanding cancer susceptibility.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile